Updated: 08/10/2011 12:45 p.m.
Thermo Fisher Scientific Inc. (NYSE:TMO) just announced plans to open an offering of senior notes to fund its upcoming $3.5 billion buyout of Swedish blood test maker Phadia. *
The offering will include notes due 2016 and notes due 2022, but the public offering price hasn’t yet been announced.